We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.82%
2 Consumer Discretionary 12.47%
3 Healthcare 12.19%
4 Financials 11.52%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FARO
1676
DELISTED
Faro Technologies
FARO
$335K ﹤0.01%
4,785
KRNT icon
1677
Kornit Digital
KRNT
$779M
$335K ﹤0.01%
+2,200
New +$338K
KRYS icon
1678
Krystal Biotech
KRYS
$9.75B
$335K ﹤0.01%
4,786
LADR
1679
Ladder Capital
LADR
$1.28B
$334K ﹤0.01%
27,865
-2,180
-7% -$25.8K
CCCC icon
1680
C4 Therapeutics
CCCC
$493M
$334K ﹤0.01%
10,375
CMPR icon
1681
Cimpress
CMPR
$2.37B
$334K ﹤0.01%
4,664
ASIX icon
1682
AdvanSix
ASIX
$453M
$333K ﹤0.01%
7,046
ANDE icon
1683
Andersons Inc
ANDE
$2.24B
$332K ﹤0.01%
8,585
OCFC icon
1684
OceanFirst Financial
OCFC
$1.9B
$332K ﹤0.01%
14,935
+349
+2% +$7.61K
AOSL icon
1685
Alpha and Omega Semiconductor
AOSL
$922M
$331K ﹤0.01%
5,472
-931
-15% -$40.3K
AIV
1686
Aimco
AIV
$379M
$331K ﹤0.01%
42,912
+230
+0.5% +$1.76K
EVOP
1687
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$331K ﹤0.01%
12,931
MMI icon
1688
Marcus & Millichap
MMI
$1.21B
$330K ﹤0.01%
6,417
CNOB icon
1689
Center Bancorp
CNOB
$1.81B
$330K ﹤0.01%
10,079
PRCH icon
1690
Porch Group
PRCH
$1.95B
$329K ﹤0.01%
21,130
CYBR
1691
DELISTED
CyberArk
CYBR
$329K ﹤0.01%
1,900
NVRI icon
1692
Enviri
NVRI
$566M
$329K ﹤0.01%
19,697
+664
+3% +$10.7K
RXDX
1693
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$329K ﹤0.01%
8,324
+4,609
+124% +$144K
ALLY icon
1694
Ally Financial
ALLY
$13.6B
$329K ﹤0.01%
6,905
-262
-4% -$13K
PBF icon
1695
PBF Energy
PBF
$8.64B
$327K ﹤0.01%
25,220
+2,976
+13% +$41.2K
GLNG icon
1696
Golar LNG
GLNG
$5.3B
$327K ﹤0.01%
26,369
-3,818
-13% -$48.7K
POLY
1697
DELISTED
Plantronics, Inc.
POLY
$327K ﹤0.01%
11,132
XRN
1698
Chiron Real Estate Inc
XRN
$496M
$327K ﹤0.01%
3,680
-8
-0.2% -$659
UIS icon
1699
Unisys
UIS
$208M
$325K ﹤0.01%
15,797
-2,250
-12% -$49.5K
SCCO icon
1700
Southern Copper
SCCO
$159B
$324K ﹤0.01%
5,737
-43
-0.7% -$2.37K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.